Clinical Trial Update: Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating levofloxacin for management of patients with abnormal PSA. The study includes conditions such as benign prostatic hyperplasia an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Prostatitis

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia, Prostatitis | Phase 3 | Status: COMPLETED